Genetics in Efavirenz Metabolism, the GEM study

Completed

• Conditions: DNA make-up; Genetic marker; 10021460

• Registration Number: NL-OMON32907
• Lead Sponsor: Medisch Centrum Haaglanden

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

All patients who are being treated with efavirenz and are monitord in the participating hospitals

Exclusion Criteria

HIV infected patients that do not use efavirenz

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Difference in variation of genetic markers, for example CYP2B6 (subtype *6, *7<br /><br>and *18), in the metabolism of efavirenz, between case and control population.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Demography of participants </p><br>